{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:20:03Z","timestamp":1787664003452,"version":"build-2736575974"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Microsatellite-stable (MSS) colorectal cancer (CRC), comprising ~85\u201390% of cases, remains almost universally refractory to PD-1\/PD-L1 monotherapy (objective response rate 5\u201310%), in stark contrast to the marked efficacy of immune checkpoint inhibitors (ICIs) in microsatellite-instability-high (MSI-H) disease. Here we synthesize evidence that CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell exclusion, dysfunction, and exhaustion in MSS CRC are orchestrated not by cell-autonomous failures but by a multicellular immunosuppressive network in which tumor-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs), regulatory T cells (Tregs), and myeloid-derived suppressor cells (MDSCs) cooperate through mechanistically distinct yet spatially integrated axes. We propose a four-layer hierarchical model (physical exclusion, effector dysfunction, metabolic deprivation, and active suppression) that culminates in a stereotyped three-layer spatial niche best documented in CRC liver metastases (outer mCAF belt, Tex\/TSTR band, inner SPP1\n                    <jats:sup>+<\/jats:sup>\n                    TAM aggregates). MSS-associated mechanisms include the TAM-derived COX2\/PGE2\/TIGIT axis driving terminal exhaustion, a functional IL-10\n                    <jats:sup>-<\/jats:sup>\n                    \/IL-10\n                    <jats:sup>+<\/jats:sup>\n                    Treg dichotomy, and CAF-mediated suppression of dendritic-cell CXCL9\/10 production that blocks CXCR3\n                    <jats:sup>+<\/jats:sup>\n                    CD8 recruitment. Effective therapeutic strategies must therefore target multiple layers simultaneously, including TAM reprogramming, stromal remodeling, precision Treg depletion, and MDSC differentiation, rather than relying on additional checkpoint inhibitors, which have proven insufficient as monotherapy or in dual combinations.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1945393","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:32:45Z","timestamp":1787661165000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multicellular immunosuppressive networks in microsatellite-stable colorectal cancer: CD8+ T cell exclusion, dysfunction, exhaustion, and therapeutic implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhiyuan","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefu","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihua","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Colorectal & Anal Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440830","article-title":"The characteristics of the tumor immune microenvironment in colorectal cancer with different msi status and current therapeutic strategies","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andre","year":"2020","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (Checkmate 142): An open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596","article-title":"Pd-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus immunoscore for the classification of colon cancer: A prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1158\/0008-5472.CAN-25-0079","article-title":"Tumor-associated macrophages produce Pge2 to promote Cd8+ T-cell exhaustion and drive resistance to Pd-L1 blockade in microsatellite-stable colorectal cancer","volume":"86","author":"Fumet","year":"2026","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"Cd8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1326-9","article-title":"Tox reinforces the phenotype and longevity of exhausted T cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1325-x","article-title":"Tox transcriptionally and epigenetically programs Cd8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1324-y","article-title":"Tox is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)Pd-1(+)Cd8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature19330","article-title":"Defining Cd8+ T cells that provide the proliferative burst after Pd-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adn1945","article-title":"Stem-like memory and precursors of exhausted T cells share a common progenitor defined by Id3 expression","volume":"10","author":"Gago da Graca","year":"2025","journal-title":"Sci Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1362140","article-title":"Precursor exhausted Cd8(+)T cells in colorectal cancer tissues associated with patient's survival and immunotherapy responsiveness","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s00262-025-04214-w","article-title":"Increased Cd103(-)Cd8(+) Tils with Tpex phenotype replenish anti-tumor T cell pool in mismatch repair-proficient Crc","volume":"74","author":"Liu","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.06.009","article-title":"Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer","volume":"42","author":"Chen","year":"2024","journal-title":"Cancer Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1654000","article-title":"Commentary: Immunogenomic characteristics and prognostic implications of terminally exhausted Cd8+ T cells in colorectal cancers","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: In vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2026.101276","article-title":"Experimental study of tumor-associated macrophage-derived Spp1 inhibit Cd8(+) T cells to promote colorectal cancer progression","volume":"73","author":"Hao","year":"2026","journal-title":"Neoplasia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of Fap(+) fibroblasts and Spp1(+) macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1739154","article-title":"Macrophage-derived chemokines in T cell regulation: Implications for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00262-024-03925-w","article-title":"Ido1 inhibitor enhances the effectiveness of Pd-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization","volume":"74","author":"Guangzhao","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102786","article-title":"Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer","volume":"7","author":"Mestrallet","year":"2026","journal-title":"Cell Rep Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-026-07978-6","article-title":"Integrated single-cell and spatial transcriptomic analysis reveals Mcaf-Spp1(+) macrophage-T cell crosstalk shaping immunosuppressive niches in colorectal cancer liver metastasis","volume":"24","author":"Chang","year":"2026","journal-title":"J Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-023-39953-w","article-title":"Il1r1(+) cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer","volume":"14","author":"Koncina","year":"2023","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"Tgfbeta attenuates tumour response to Pd-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1038\/s41467-025-66485-2","article-title":"Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer","volume":"16","author":"Iwane","year":"2025","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-025-07636-3","article-title":"Senescent fibroblasts drive Cd8(+) T cell dysfunction in colorectal cancer via Cd36-mediated lipid transfer and peroxidation","volume":"24","author":"Ge","year":"2026","journal-title":"J Transl Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-026-08413-w","article-title":"Cancer-associated fibroblasts (Cafs) derived from Mfap2 promote Crc proliferation and metastasis while suppressing Cd8(+) T cell-mediated antitumor immunity","volume":"17","author":"Zhang","year":"2026","journal-title":"Cell Death Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322924","article-title":"Targeting cancer-associated fibroblast-secreted Wnt2 restores dendritic cell-mediated antitumour immunity","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09303-5","article-title":"Nnmt inhibition in cancer-associated fibroblasts restores antitumour immunity","volume":"645","author":"Heide","year":"2025","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101231","article-title":"Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics","volume":"4","author":"Qin","year":"2023","journal-title":"Cell Rep Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"Ccl19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor Igg response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Nishikawa","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in cancers: A systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12967-024-05518-8","article-title":"Targeting tumor-infiltrating Ccr8(+) regulatory T cells induces antitumor immunity through functional restoration of Cd4(+) T(Convs) and Cd8(+) T cells in colorectal cancer","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.11.014","article-title":"Opposing functions of distinct regulatory T cell subsets in colorectal cancer","volume":"59","author":"Huang","year":"2026","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s40425-019-0757-z","article-title":"Il-17 inhibits Cxcl9\/10-mediated recruitment of Cd8(+) cytotoxic T cells and regulatory T cells to colorectal tumors","volume":"7","author":"Chen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cyto.2018.12.021","article-title":"Il-17 and colorectal cancer: From carcinogenesis to treatment","volume":"116","author":"Razi","year":"2019","journal-title":"Cytokine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00262-024-03794-3","article-title":"Preclinical development of a novel Ccr8\/Ctla-4 bispecific antibody for cancer treatment by disrupting Ctla-4 signaling on Cd8 T cells and specifically depleting tumor-resident Tregs","volume":"73","author":"Guo","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cancers15225484","article-title":"Targeting myeloid-derived suppressor cell trafficking as a novel immunotherapeutic approach in microsatellite stable colorectal cancer","volume":"15","author":"Johnson","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.02.008","article-title":"Kras-Irf2 axis drives immune suppression and immune therapy resistance in colorectal cancer","volume":"35","author":"Liao","year":"2019","journal-title":"Cancer Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1742654","article-title":"Roles of immunosuppressive myeloid states in colorectal cancer checkpoint inhibitor non-response: Single-cell and spatial proteomics, and reprogramming approaches","volume":"16","author":"Dai","year":"2025","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting M(6)a reader Ythdf1 augments antitumour immunity and boosts anti-Pd-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"Pd-L1 is a novel direct target of Hif-1alpha, and its blockade under hypoxia enhanced Mdsc-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41419-025-08228-1","article-title":"Downregulated Smad3 signaling impairs the maturation of Mo-Mdsc in colorectal cancer","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nature25492","article-title":"Tgfbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"182","author":"Schurch","year":"2020","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (Time) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/jitc-2022-006425","article-title":"Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases","volume":"11","author":"Zhang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03182-9","article-title":"Targeting Pd-L1 and Tigit could restore intratumoral Cd8 T cell function in human colorectal cancer","volume":"71","author":"Thibaudin","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0002","article-title":"Nivolumab and relatlimab for the treatment of patients with unresectable or metastatic mismatch repair-proficient colorectal cancer","volume":"31","author":"Christenson","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.08.019","article-title":"Fusobacterium nucleatum facilitates anti-Pd-1 therapy in microsatellite stable colorectal cancer","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.70210","article-title":"Cotargeting Trem2 and Il2 pathways triggers multipronged anticancer immunity","volume":"20","author":"Vanmeerbeek","year":"2026","journal-title":"Mol Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-329147","article-title":"Targeting Ms4a4a on tumour-associated macrophages restores Cd8+ T-cell-mediated antitumour immunity","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300067","article-title":"Immunotherapy targeting Ccr8+ regulatory T cells induces antitumor effects via dramatic changes to the intratumor Cd8+ T cell profile","volume":"211","author":"Ueyama","year":"2023","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nature19834","article-title":"Pi3kgamma is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmogo.2025.100226","article-title":"Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the Purple trial","volume":"9","author":"Kasper","year":"2025","journal-title":"ESMO Gastrointest Oncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03250-w","article-title":"Neoadjuvant nivolumab and relatlimab in locally advanced Mmr-deficient colon cancer: A phase 2 trial","volume":"30","author":"de Gooyer","year":"2024","journal-title":"Nat Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02261","article-title":"Randomized phase Ii trial of immunotherapy-based total neoadjuvant therapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (Torch)","volume":"42","author":"Xia","year":"2024","journal-title":"J Clin Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03083-7","article-title":"Botensilimab plus balstilimab in relapsed\/refractory microsatellite stable metastatic colorectal cancer: A phase 1 trial","volume":"30","author":"Bullock","year":"2024","journal-title":"Nat Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-025-01753-3","article-title":"Cd160 dictates anti-Pd-1 immunotherapy resistance by regulating Cd8(+) T cell exhaustion in colorectal cancer","volume":"27","author":"Zheng","year":"2025","journal-title":"Nat Cell Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1945393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:32:46Z","timestamp":1787661166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1945393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":84,"alternative-id":["10.3389\/fimmu.2026.1945393"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1945393","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1945393"}}